{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:00:19Z","timestamp":1793426419422,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":6702,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutrition"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1093\/jn\/134.10.2842s","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T02:13:22Z","timestamp":1516587202000},"page":"2842S-2847S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":301,"title":["Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Explains the \u201cL-Arginine Paradox\u201d and Acts as a Novel Cardiovascular Risk Factor"],"prefix":"10.1016","volume":"134","author":[{"given":"Rainer H.","family":"B\u00f6ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/jn\/134.10.2842S_bib1","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"ADMA: a novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia","volume":"98","author":"B\u00f6ger","year":"1998","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199007053230105","article-title":"Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension","volume":"323","author":"Panza","year":"1990","journal-title":"N. Engl. J. Med"},{"key":"10.1093\/jn\/134.10.2842S_bib3","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.88.5.2149","article-title":"Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults","volume":"88","author":"Celermajer","year":"1993","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib4","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1161\/01.CIR.88.6.2510","article-title":"Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus","volume":"88","author":"Johnstone","year":"1993","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/01.CIR.95.5.1119","article-title":"Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans","volume":"95","author":"Tawakol","year":"1997","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib6","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.CIR.102.9.994","article-title":"Acute systemic inflammation impairs endothelium-dependent dilatation in humans","volume":"102","author":"Hingorani","year":"2000","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"10.1093\/jn\/134.10.2842S_bib8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.CIR.83.3.1057","article-title":"Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta","volume":"83","author":"Cooke","year":"1991","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0021-9150(95)05582-H","article-title":"Supplementation of hypercholesterolaemic rabbits with l-arginine reduces the vascular release of superoxide anions and restores NO production","volume":"117","author":"B\u00f6ger","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1093\/jn\/134.10.2842S_bib10","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/01.CIR.96.4.1282","article-title":"Dietary l-arginine slows the progression of atherosclerosis in cholesterol-fed rabbits\u2014comparison with lovastatin","volume":"96","author":"B\u00f6ger","year":"1997","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.ATV.16.1.44","article-title":"Regression or progression. Dependency on vascular nitric oxide","volume":"16","author":"Candipan","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1093\/jn\/134.10.2842S_bib12","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/01.ATV.14.10.1529","article-title":"l-Arginine attenuates platelet reactivity in hypercholesterolemic rabbits","volume":"14","author":"Tsao","year":"1994","journal-title":"Arterioscler. Thromb"},{"key":"10.1093\/jn\/134.10.2842S_bib13","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/01.CIR.89.5.2176","article-title":"Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by l-arginine","volume":"89","author":"Tsao","year":"1994","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0021-9150(97)00183-4","article-title":"Dietary l-arginine decreases myointimal cell proliferation and vascular leukocyte accumulation in cholesterol-fed rabbits","volume":"136","author":"B\u00f6ger","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1093\/jn\/134.10.2842S_bib15","first-page":"354","article-title":"l-Arginine does not restore endothelial dysfunction in atherosclerotic rabbit aorta in vitro","volume":"28","author":"M\u00fcgge","year":"1991","journal-title":"Blood Vessels"},{"key":"10.1093\/jn\/134.10.2842S_bib16","doi-asserted-by":"crossref","first-page":"10480","DOI":"10.1073\/pnas.88.23.10480","article-title":"Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells","volume":"88","author":"Pollock","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1093\/jn\/134.10.2842S_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.pharmtox.41.1.79","article-title":"The clinical pharmacology of l-arginine","volume":"41","author":"B\u00f6ger","year":"2001","journal-title":"Annu. Rev. Pharmacol"},{"key":"10.1093\/jn\/134.10.2842S_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0140-6736(92)90389-K","article-title":"Reduced plasma l-arginine in hypercholesterolemia","volume":"339","author":"Jeserich","year":"1992","journal-title":"Lancet"},{"key":"10.1093\/jn\/134.10.2842S_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(00)01686-0","article-title":"Hypothesis: endogenous nitric oxide synthase inhibitors are responsible for the l-arginine paradox","volume":"23810","author":"Tsikas","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1093\/jn\/134.10.2842S_bib20","first-page":"H2224","article-title":"Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules","volume":"268","author":"Kurose","year":"1995","journal-title":"Am. J. Physiol"},{"key":"10.1093\/jn\/134.10.2842S_bib21","first-page":"H1522","article-title":"Response of cerebral blood vesels to an endogenous inhibitor of nitric oxide synthase","volume":"269","author":"Faraci","year":"1995","journal-title":"Am. J. Physiol"},{"key":"10.1093\/jn\/134.10.2842S_bib22","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1161\/01.STR.30.10.2206","article-title":"Effects of some guanidino compounds on human cerebral arteries","volume":"30","author":"Segarra","year":"1999","journal-title":"Stroke"},{"issue":"Suppl. 12","key":"10.1093\/jn\/134.10.2842S_bib23","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1097\/00005344-199204002-00018","article-title":"Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis","volume":"20","author":"Vallance","year":"1992","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"10.1093\/jn\/134.10.2842S_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/10623329309102688","article-title":"Synthesis of NG,NG-dimethylarginine by human endothelial cells","volume":"1","author":"Fickling","year":"1993","journal-title":"Endothelium"},{"key":"10.1093\/jn\/134.10.2842S_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-4347(00)00142-0","article-title":"Assessment of nitric oxide synthase activity by gas chromatography-mass spectrometry","volume":"742","author":"Tsikas","year":"2000","journal-title":"J. Chromatogr. B"},{"key":"10.1093\/jn\/134.10.2842S_bib26","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1476-5381.1996.tb16069.x","article-title":"Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase","volume":"119","author":"MacAllister","year":"1996","journal-title":"Br. J. Pharmacol"},{"issue":"suppl.","key":"10.1093\/jn\/134.10.2842S_bib27","first-page":"I","article-title":"Asymmetric dimethylarginine enhances superoxide production in human endothelial cells","volume":"96","author":"Lin","year":"1997","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib28","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1161\/01.CIR.0000101924.04515.2E","article-title":"Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence","volume":"108","author":"Dayoub","year":"2003","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib29","first-page":"193","article-title":"1993. Effect of local intra-arterial asymmetric dimethylarginine (ADMA) on the forearm arteriolar bed of healthy volunteers","volume":"7","author":"Calver","year":"1993","journal-title":"J. Hum. Hypertens"},{"key":"10.1093\/jn\/134.10.2842S_bib30","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/01.ATV.0000081742.92006.59","article-title":"Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolised by dimethylarginine dimethylaminohydolase","volume":"23","author":"Achan","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1093\/jn\/134.10.2842S_bib31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/01.CIR.0000105764.22626.B1","article-title":"Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans","volume":"109","author":"Kielstein","year":"2004","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib32","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0008-6363(03)00500-5","article-title":"The emerging role of ADMA as a novel cardiovascular risk factor","volume":"59","author":"B\u00f6ger","year":"2003","journal-title":"Cardiovasc. Res"},{"key":"10.1093\/jn\/134.10.2842S_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0968-0004(98)01185-2","article-title":"Protein methylation: a signal event in post-translational modification","volume":"23","author":"Aletta","year":"1998","journal-title":"Trends Biochem. Sci"},{"key":"10.1093\/jn\/134.10.2842S_bib34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1681\/ASN.V103594","article-title":"Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease","volume":"10","author":"Kielstein","year":"1999","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1093\/jn\/134.10.2842S_bib35","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase predicts mortality in end-stage renal disease (ESRD)","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"10.1093\/jn\/134.10.2842S_bib36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jb\/117.2.237","article-title":"1995. Detection of NG,NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody","volume":"117","author":"Kimoto","year":"1995","journal-title":"J. Biochem"},{"key":"10.1093\/jn\/134.10.2842S_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bj3430209","article-title":"Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases","volume":"343","author":"Leiper","year":"1999","journal-title":"Biochem. J"},{"key":"10.1093\/jn\/134.10.2842S_bib38","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1161\/01.CIR.99.24.3092","article-title":"Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase","volume":"99","author":"Ito","year":"1999","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib39","doi-asserted-by":"crossref","first-page":"13527","DOI":"10.1073\/pnas.212269799","article-title":"S-Nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase","volume":"99","author":"Leiper","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1093\/jn\/134.10.2842S_bib40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0008-6363(02)00617-X","article-title":"ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia. Effects of l-arginine and B vitamins","volume":"57","author":"Sydow","year":"2003","journal-title":"Cardiovasc. Res"},{"key":"10.1093\/jn\/134.10.2842S_bib41","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(01)02063-X","article-title":"Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus","volume":"88","author":"Abbasi","year":"2001","journal-title":"Am. J. Cardiol"},{"key":"10.1093\/jn\/134.10.2842S_bib42","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/01.CIR.95.8.2068","article-title":"Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease","volume":"95","author":"B\u00f6ger","year":"1997","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib43","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00004872-199715080-00015","article-title":"Nitric oxide synthase inhibitors and hypertension in children and adolescents","volume":"15","author":"Goonasekera","year":"1997","journal-title":"J. Hypertens"},{"key":"10.1093\/jn\/134.10.2842S_bib44","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00005344-199904000-00020","article-title":"Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetrical dimethylarginine in men with essential hypertension","volume":"33","author":"Surdacki","year":"1999","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"10.1093\/jn\/134.10.2842S_bib45","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/S0024-3205(98)00225-2","article-title":"Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure","volume":"62","author":"Usui","year":"1998","journal-title":"Life Sci"},{"key":"10.1093\/jn\/134.10.2842S_bib46","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet"},{"key":"10.1093\/jn\/134.10.2842S_bib47","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.99.9.1141","article-title":"Endogenous nitric oxide synthase inhibitor. A novel marker of atherosclerosis","volume":"99","author":"Miyazaki","year":"1999","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib48","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1681\/ASN.V132490","article-title":"Asymmetric dimethylarginine (ADMA), C-reactive protein, and carotid intima media-thickness in end-stage renal disease","volume":"13","author":"Zoccali","year":"2002","journal-title":"J. Am. Soc. Nephrol"},{"issue":"suppl.","key":"10.1093\/jn\/134.10.2842S_bib49","doi-asserted-by":"crossref","first-page":"515A","DOI":"10.1016\/S0735-1097(04)92181-X","article-title":"Asymmetric dimethylarginine and the risk of coronary heart disease: relationship with traditional risk factors as assessed in the multicenter CARDIAC study","volume":"43","author":"B\u00f6ger","year":"2004","journal-title":"J. Am. Coll. Cardiol"},{"key":"10.1093\/jn\/134.10.2842S_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1054\/clnu.2002.0613","article-title":"Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality","volume":"22","author":"Nijveldt","year":"2003","journal-title":"Clin. Nutr"},{"key":"10.1093\/jn\/134.10.2842S_bib51","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.ehj.2003.08.013","article-title":"Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention","volume":"24","author":"Lu","year":"2003","journal-title":"Eur. Heart J"},{"issue":"suppl.","key":"10.1093\/jn\/134.10.2842S_bib52","first-page":"I","article-title":"Plasma levels of ADMA are increased and inversely related to endothelium-mediated vasodilation in patients with chronic heart failure: a new predictor of endothelial dysfunction?","volume":"98","author":"Hornig","year":"1998","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib53","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1476-5381.1995.tb15910.x","article-title":"Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of l-arginine in regenerated endothelial cells","volume":"115","author":"Azuma","year":"1995","journal-title":"Br. J. Pharmacol"},{"key":"10.1093\/jn\/134.10.2842S_bib54","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/0735-1097(93)90239-W","article-title":"Response of human coronary arteries after injury by coronary angioplasty","volume":"21","author":"el-Tamimi","year":"1993","journal-title":"J. Am. Coll. Cardiol"},{"key":"10.1093\/jn\/134.10.2842S_bib55","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1161\/01.CIR.95.7.1863","article-title":"Local intramural delivery of l-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty","volume":"95","author":"Schwarzacher","year":"1997","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib56","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.10.2842S_bib57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1191\/1358863x03vm490oa","article-title":"2003. Plasma asymmetric dimethylarginine modifies the effect of pravastatin on myocardial blood flow in young adults","volume":"8","author":"Janatuinen","year":"2003","journal-title":"Vasc. Med"},{"key":"10.1093\/jn\/134.10.2842S_bib58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1191\/1358863x03vm501ed","article-title":"Asymmetric dimethylarginine (ADMA) modulates endothelial function\u2014therapeutic implications [Editorial]","volume":"8","author":"B\u00f6ger","year":"2003","journal-title":"Vasc. Med"},{"issue":"suppl.","key":"10.1093\/jn\/134.10.2842S_bib59","doi-asserted-by":"crossref","first-page":"525A","DOI":"10.1016\/S0735-1097(04)92228-0","article-title":"Improvement of endothelium-dependent vasodilation by simvastatin is potentiated by combination with l-arginine in patients with elevated asymmetric dimethylarginine levels","volume":"43","author":"B\u00f6ger","year":"2004","journal-title":"J. Am. Coll. Cardiol"},{"key":"10.1093\/jn\/134.10.2842S_bib60","unstructured":"ADMA Spiegel [Online]. www.adma-spiegel.de [accessed April 28, 2004]."},{"key":"10.1093\/jn\/134.10.2842S_bib61","unstructured":"DLD Diagnostika [Online]. www.dld-diagnostika.de [accessed April 28, 2004]."}],"container-title":["The Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316623031395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316623031395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/jn\/article-pdf\/134\/10\/2842S\/24028006\/z4w110040s2842.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T13:55:39Z","timestamp":1686578139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022316623031395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0022316623031395"],"URL":"https:\/\/doi.org\/10.1093\/jn\/134.10.2842s","relation":{},"ISSN":["0022-3166"],"issn-type":[{"value":"0022-3166","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Explains the \u201cL-Arginine Paradox\u201d and Acts as a Novel Cardiovascular Risk Factor","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/jn\/134.10.2842S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}